GlassScriptPhysician profile
Marcie M Nichols
NPI 1235241993
$3,964.42
in general payments reported to CMS, 2019-2025
7 companies · $1,882 in 2025
The $1,882 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $183 · 2021: $414 · 2022: $279 · 2023: $310 · 2024: $677 · 2025: $1,882.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,869.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,868.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,957.62 | 2019-2025 | Total30, Precision7, Precision 1 |
| Lumenis Be INC | $1,247.09 | 2025 | Optilight |
| Johnson & Johnson Vision Care, INC. | $401.26 | 2019-2025 | Acuvue |
| Coopervision INC. | $212.43 | 2022-2024 | Myday Contact Lens |
| Optos, INC. | $84.77 | 2020 | |
| Novartis Pharmaceuticals Corporation | $32.06 | 2021-2022 | |
| Abb Con-Cise Optical Group LLC | $29.19 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcie Nichols listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.